Fluoxetine and levothyroxine: potential drug interaction

被引：0
作者：
机构：
来源：
Reactions Weekly | 2020年 / 1807卷 / 1期
关键词：
D O I：
10.1007/s40278-020-79288-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [31] INTERACTION OF METOPROLOL AND FLUOXETINE
    WALLEY, T
    PIRMOHAMED, M
    PROUDLOVE, C
    MAXWELL, D
    LANCET, 1993, 341 (8850) : 967 - 968
  • [32] INTERACTION OF FLUOXETINE AND SELEGILINE
    SUCHOWERSKY, O
    DEVRIES, JD
    CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 1990, 35 (06): : 571 - 572
  • [33] INTERACTION OF FLUOXETINE WITH CARBAMAZEPINE
    PEARSON, HJ
    JOURNAL OF CLINICAL PSYCHIATRY, 1990, 51 (03) : 125 - 126
  • [34] INTERACTION OF PHENYTOIN AND FLUOXETINE
    WOODS, DJ
    COULTER, DM
    PILLANS, P
    NEW ZEALAND MEDICAL JOURNAL, 1994, 107 (970) : 19 - 19
  • [35] INTERACTION OF FLUOXETINE AND PENTAZOCINE
    HANSEN, TE
    DIETER, K
    KEEPERS, GA
    AMERICAN JOURNAL OF PSYCHIATRY, 1990, 147 (07) : 949 - 950
  • [36] Biperiden/fluoxetine/risperidoneAcute dystonia secondary to drug interaction and delirium: case report
    Reactions Weekly, 2019, 1746 (1) : 49 - 49
  • [37] Screening of drug candidates for their drug-drug interaction potential
    Rodrigues, AD
    Lin, JH
    CURRENT OPINION IN CHEMICAL BIOLOGY, 2001, 5 (04) : 396 - 401
  • [38] Drug Interaction of Fluvoxamine and Fluoxetine with Nevirapine in HIV-1-Infected Individuals
    Monique M. R. de Maat
    Alwin D. R. Huitema
    Jan W. Mulder
    Pieter L. Meenhorst
    Eric C. M. van Gorp
    Albert T. A. Mairuhu
    Jos H. Beijnen
    Clinical Drug Investigation, 2003, 23 : 629 - 637
  • [39] PBPK MODELING TO ASSESS PHARMACOGENETIC IMPLICATIONS ON THE FLUOXETINE-CLOPIDOGREL DRUG-DRUG INTERACTION.
    Miles, N.
    Quinney, S.
    Bergstrom, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S36 - S37
  • [40] Drug interaction of fluvoxamine and fluoxetine with nevirapine in HIV-1-infected individuals
    de Maat, MM
    Huitema, ADR
    Mulder, JW
    Meenhorst, PL
    van Gorp, ECM
    Mairuhu, ATA
    Beijnen, JH
    CLINICAL DRUG INVESTIGATION, 2003, 23 (10) : 629 - 637
12345